Pegah Shahbazian1, Maryam Izad2,3, Maryam Daneshpazhooh1, Hossein Mortazavi3, Zahra Salehi2, Shirin Behruzifar1, Soheil Tavakolpour1,4, Arghavan Azizpour1. 1. Autoimmune Bullous Diseases Research Center, Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran. 2. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. 3. MS Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran. 4. Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.
Authors: Dedee F Murrell; Sarah Dick; A R Ahmed; Masayuki Amagai; Maria A Barnadas; Luca Borradori; Jean-Claude Bystryn; Giuseppe Cianchini; Luis Diaz; David Fivenson; Russell Hall; Karen E Harman; Takashi Hashimoto; Michael Hertl; Nico Hunzelmann; Pilar Iranzo; Pascal Joly; Marcel F Jonkman; Yasuo Kitajima; Neil J Korman; Linda K Martin; Daniel Mimouni; Amit G Pandya; Aimee S Payne; David Rubenstein; Hiroshi Shimizu; Animesh A Sinha; David Sirois; Detlef Zillikens; Victoria P Werth Journal: J Am Acad Dermatol Date: 2008-03-14 Impact factor: 11.527
Authors: Mohammad A El-Darouti; Rehab A Hegazy; Rania M Abdel Hay; Marwa S El Hawary; Amira M Tawdy; Marwa M Fawzy; Laila A Rashed Journal: Arch Dermatol Res Date: 2014-12-02 Impact factor: 3.017
Authors: Christian M Veldman; Kerstin L Gebhard; Wolfgang Uter; Ralf Wassmuth; Joachim Grötzinger; Erwin Schultz; Michael Hertl Journal: J Immunol Date: 2004-03-15 Impact factor: 5.422
Authors: Tina Hennerici; Robert Pollmann; Thomas Schmidt; Maria Seipelt; Björn Tackenberg; Christian Möbs; Kamran Ghoreschi; Michael Hertl; Rüdiger Eming Journal: PLoS One Date: 2016-02-12 Impact factor: 3.240